Host matters: medicinal leech digestive-tract symbionts and their pathogenic potential

Digestive-tract microbiota exert tremendous influence over host health. Host-symbiont model systems are studied to investigate how symbioses are initiated and maintained, as well as to identify host processes affected by resident microbiota. The medicinal leech, Hirudo verbana, is an excellent model to address such questions owing to a microbiome that is consistently dominated by two species, Aeromonas veronii and Mucinivorans hirudinis, both of which are cultivable and have sequenced genomes. This review outlines current knowledge about the dynamics of the H. verbana microbiome. We discuss in depth the factors required for A. veronii colonization and proliferation in the leech crop and summarize the current understanding of interactions between A. veronii and its annelid host. Lastly, we discuss leech usage in modern medicine and highlight how leech-therapy associated infections, often attributable to Aeromonas spp., are of growing clinical concern due in part to an increased prevalence of fluoroquinolone resistant strains.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

This review examines the digestive-tract microbiome of the medicinal leech Hirudo verbana, dominated by Aeromonas veronii and Mucinivorans hirudinis, detailing factors governing A. veronii colonization of the leech crop and noting that Aeromonas-associated leech-therapy infections are a growing concern amid rising fluoroquinolone resistance.

Explore how this research connects to clinical practice

More peer-reviewed studies in Safety & Infection Control.

• Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
• Hirudotherapy (medicinal leeches) for treatment of upper airway obstruction in a dog — Trenholme H, Masseau I, Reinero C (2021)
• Analysis of antibiotic resistant infections associated with hirudotherapy — Brauer P et al. (2024)
• Kounis syndrome due to hirudotherapy (leech therapy) in emergency department; a case report — Çakmak T et al. (2018)
• Complications of leech therapy — Pourrahimi M, Abdi M, Ghods R (2020)
• Medicinal leech therapy and Aeromonas spp. infection — Verriere B et al. (2016)
• Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy — McCracken J, Koehler S, Sharma R (2022)
• Prophylactic use of levofloxacin during medicinal leech therapy — Bauters T et al. (2014)
• Leech Application-related Upper Gastrointestinal Bleeding: A Case Report — Dolek U et al. (2023)
• A clinical trial for evaluation of leech application in the management of Vicarcikā (Eczema) — Shankar K et al. (2014)

Browse all ASH-analysed research →